DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,033,948 | -0.9% | 8,136 | -1.6% | 0.06% | -16.7% |
Q3 2023 | $2,051,457 | -2.1% | 8,269 | -5.2% | 0.07% | -1.4% |
Q2 2023 | $2,096,131 | -0.6% | 8,724 | +4.4% | 0.07% | -5.2% |
Q1 2023 | $2,108,903 | -4.0% | 8,358 | +1.1% | 0.08% | -2.5% |
Q4 2022 | $2,195,988 | +13.5% | 8,266 | +10.5% | 0.08% | +1.3% |
Q3 2022 | $1,934,000 | +1.9% | 7,479 | -0.0% | 0.08% | +11.4% |
Q2 2022 | $1,898,000 | -4.7% | 7,480 | +10.2% | 0.07% | +7.7% |
Q1 2022 | $1,992,000 | -11.8% | 6,786 | -1.0% | 0.06% | -8.5% |
Q4 2021 | $2,258,000 | +8.1% | 6,858 | 0.0% | 0.07% | -9.0% |
Q3 2021 | $2,089,000 | +7.6% | 6,858 | -5.1% | 0.08% | +5.4% |
Q2 2021 | $1,942,000 | +260.3% | 7,230 | +202.1% | 0.07% | +208.3% |
Q1 2021 | $539,000 | -1.5% | 2,393 | -2.8% | 0.02% | -35.1% |
Q4 2020 | $547,000 | -24.7% | 2,461 | -26.9% | 0.04% | -37.3% |
Q3 2020 | $726,000 | +16.3% | 3,368 | -4.5% | 0.06% | -1.7% |
Q2 2020 | $624,000 | -99.9% | 3,526 | -14.5% | 0.06% | -25.9% |
Q1 2020 | $571,691,000 | -9.5% | 4,125 | -5.5% | 0.08% | +3.8% |
Q3 2019 | $631,472,000 | – | 4,367 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |